Literature DB >> 16643859

Cross-talk between angiotensin II and glucagon receptor signaling mediates phosphorylation of mitogen-activated protein kinases ERK 1/2 in rat glomerular mesangial cells.

Xiao C Li1, Oscar A Carretero, Jia L Zhuo.   

Abstract

We have recently shown that the pancreatic hormone glucagon-induced phosphorylation of mitogen-activated protein (MAP) kinase ERK 1/2 as well as growth and proliferation of rat glomerular mesangial cells (MCs) via activation of cAMP-dependent protein kinase A (PKA)- and phospholipase C (PLC)/Ca2+-mediated signaling pathways. Since circulating glucagon and tissue angiotensin II (Ang II) levels are inappropriately elevated in type 2 diabetes, we tested the hypothesis that glucagon induces phosphorylation of ERK 1/2 in MCs by interacting with Ang II receptor signaling. Stimulation of MCs by glucagon (10 nM) induced a marked increase in intracellular [Ca2+]i that was abolished by [Des-His1, Glu9]-glucagon (1 microM), a selective glucagon receptor antagonist. Both glucagon and Ang II-induced ERK 1/2 phosphorylation (glucagon: 214+/-14%; Ang II: 174+/-16%; p<0.001 versus control), and these responses were inhibited by the AT1 receptor blocker losartan (glucagon + losartan: 77+/-14%; Ang II + losartan: 84+/-18%; p<0.01 versus glucagon or Ang II) and the AT2 receptor blocker PD 123319 (glucagon + PD: 78+/-7%; Ang II + PD: 87+/-7%; p<0.01 versus glucagon or Ang II). Inhibition of cAMP-dependent PKA with H89 (1 microM) or PLC with U73122 (1 microM) also markedly attenuated the phosphorylation of ERK 1/2 induced by glucagon (glucagon + U73122: 109+/-15%; glucagon + H89: 113+/-16%; p<0.01 versus glucagon) or Ang II (Ang II + U73122: 111+/-13%; Ang II + H89: 86+/-10%; p<0.01 versus Ang II). Wortmannin (1 microM), a selective PI 3-kinase inhibitor, also blocked glucagon- or Ang II-induced ERK 1/2 phosphorylation. These results suggest that AT1 receptor-activated cAMP-dependent PKA, PLC and PI 3-kinase signaling is involved in glucagon-induced MAP kinase ERK 1/2 phosphorylation in MCs. The inhibitory effect of PD 123319 on glucagon-induced ERK 1/2 phosphorylation further suggests that AT2 receptors also play a similar role in this response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643859      PMCID: PMC2276839          DOI: 10.1016/j.bcp.2006.03.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  46 in total

1.  Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C.

Authors:  Xiao C Li; Oscar A Carretero; Yuan Shao; Jia L Zhuo
Journal:  Hypertension       Date:  2006-01-03       Impact factor: 10.190

2.  Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.

Authors:  J Zhuo; M Ohishi; F A Mendelsohn
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

3.  Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli.

Authors:  M J Kang; X Wu; H Ly; K Thai; J W Scholey
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

Review 4.  Novel aspect of angiotensin receptors and signal transduction in the kidney.

Authors:  J G Douglas; U Hopfer
Journal:  Annu Rev Physiol       Date:  1994       Impact factor: 19.318

5.  The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.

Authors:  Angelo D'Amore; M Jane Black; Walter G Thomas
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

Review 6.  The effects of improved glycemic control on complications in type 2 diabetes.

Authors:  B Gaster; I B Hirsch
Journal:  Arch Intern Med       Date:  1998-01-26

7.  AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats.

Authors:  Xiao C Li; Duncan J Campbell; Mitsuru Ohishi; Shao Yuan; Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-27

8.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

Authors:  Anthony H Barnett; Stephen C Bain; Paul Bouter; Bengt Karlberg; Sten Madsbad; Jak Jervell; Jukka Mustonen
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

9.  Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.

Authors:  R Singh; N Alavi; A K Singh; D J Leehey
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

10.  AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases.

Authors:  Xiao C Li; Oscar A Carretero; L Gabriel Navar; Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14
View more
  9 in total

Review 1.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

2.  AT1a receptor signaling is required for basal and water deprivation-induced urine concentration in AT1a receptor-deficient mice.

Authors:  Xiao C Li; Yuan Shao; Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2012-06-27

3.  cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway.

Authors:  Bing Shen; Hiu-Yee Kwan; Xin Ma; Ching-On Wong; Juan Du; Yu Huang; Xiaoqiang Yao
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

4.  AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla.

Authors:  Xiao C Li; Yuan Shao; Jia L Zhuo
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

5.  Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of Type 2 diabetes in mice.

Authors:  Xiao C Li; Tang-Dong Liao; Jia L Zhuo
Journal:  Clin Sci (Lond)       Date:  2008-05       Impact factor: 6.124

6.  High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.

Authors:  Masayo Naito; Ananth Shenoy; Isao Aoyama; Joseph S Koopmeiners; Radko Komers; H William Schnaper; Karol Bomsztyk
Journal:  Am J Nephrol       Date:  2009-02-19       Impact factor: 3.754

Review 7.  Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Clin Sci (Lond)       Date:  2007-08       Impact factor: 6.124

8.  Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).

Authors:  David Chiluiza; Sneha Krishna; Valérie A Schumacher; Johannes Schlöndorff
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

9.  Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.

Authors:  Hua-Xing Huang; Liang-Lan Shen; Hai-Yan Huang; Li-Hua Zhao; Feng Xu; Dong-Mei Zhang; Xiu-Lin Zhang; Tong Chen; Xue-Qin Wang; Yan Xie; Jian-Bin Su
Journal:  Diabetes Metab J       Date:  2021-03-23       Impact factor: 5.376

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.